FY19 facilities to b

Ended Awarded Last action

Contract number
75N91019F00142
Awardee
Awarding agency
Obligated
$11,193,302

Award facts

Opportunity
  • NCIOSFM190033 Solicitation number
Contract value 100% obligated
$11,193,302.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Frederick, MD 21702, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00011 · FY19 facilities to b MOD 011 $0
Other Administrative Action P00010 · FY19 facilities to b MOD 010 $0
Other Administrative Action P00009 · FY19 facilities to b MOD 009 $28,437
Other Administrative Action P00008 · FY19 facilities to b MOD 008 $0
Other Administrative Action P00007 $418,820
Other Administrative Action P00006 $49,926
Other Administrative Action P00005 · FY19 facilities to b MOD 005 $130,634
Other Administrative Action P00004 $579,163
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $9,986,322
Show all 12

About this award

Written by GovTribe AI ·

This contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH), specifically the National Cancer Institute, to the prime contractor Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The award has a potential value of $11,193,302.00 and is a delivery order contract with a cost-plus-fixed-fee pricing structure. The contract was awarded on September 25, 2019, with a completion date of August 30, 2024. This contract is not set aside for any specific business type.

Leidos Biomedical Research is an experienced provider of research, development, and production services to federal agencies, particularly in support of biomedical research programs at the NIH. The company has a history of prime and subcontractor awards from the NIH's National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Center for Advancing Translational Sciences, providing a range of services including facilities operations and maintenance, research and development, manufacturing, and clinical trials management. This contract represents ongoing support for the NIH's biomedical research efforts across various disease areas.

Quick answers

Who was awarded contract 75N91019F00142?

75N91019F00142 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 25, 2019.

How much is contract 75N91019F00142 worth?

The government has obligated $11,193,302 on 75N91019F00142.

Is contract 75N91019F00142 an order under another contract?

Yes. 75N91019F00142 is a delivery order under 75N91019D00024, an indefinite delivery contract.

Was contract 75N91019F00142 competed?

The extent of competition for 75N91019F00142 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login